KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Amortization (2016 - 2020)

Aurinia Pharmaceuticals filings provide 4 years of Amortization readings, the most recent being -$37.0 million for Q3 2020.

  • On a quarterly basis, Amortization fell 124.52% to -$37.0 million in Q3 2020 year-over-year; TTM through Sep 2020 was -$2.5 million, a 101.67% decrease, with the full-year FY2019 number at $326.7 million, up 123.97% from a year prior.
  • Amortization hit -$37.0 million in Q3 2020 for Aurinia Pharmaceuticals, down from -$21.9 million in the prior quarter.
  • In the past five years, Amortization ranged from a high of $189.8 million in Q4 2017 to a low of -$37.0 million in Q3 2020.
  • Median Amortization over the past 4 years was $21.2 million (2019), compared with a mean of $59.8 million.
  • Biggest five-year swings in Amortization: soared 97.53% in 2019 and later plummeted 255.52% in 2020.
  • Aurinia Pharmaceuticals' Amortization stood at $189.8 million in 2017, then plummeted by 92.3% to $14.6 million in 2018, then surged by 97.53% to $28.9 million in 2019, then plummeted by 228.02% to -$37.0 million in 2020.
  • The last three reported values for Amortization were -$37.0 million (Q3 2020), -$21.9 million (Q2 2020), and $27.5 million (Q1 2020) per Business Quant data.